Telehealth and Remote Blood Pressure
Part of paid clinical trials in Winston-Salem, North Carolina.
- Sponsor
- Wake Forest University Health Sciences
- Study ID
- NCT07356518
- Status
- Recruiting
Conditions
- Hypertension
- Hypertension in Pregnancy
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Not accepted
Interventions
- Telehealth visits — BEHAVIORALremote visits with participants
- In-person visits — BEHAVIORALstandard of care visits with care provider in person
Study Details
The purpose of this research study is to compare the management of chronic hypertension during pregnancy using telehealth visits with blood pressure telemonitoring and health coaching as compared to standard in person clinic visits. The study involves pregnant woman aged 18-45 who are receiving care for chronic hypertension. Participation in this research study will last until their baby is delivered. The number of in-person clinic visits depends on the participant's treatment assignment. Those assigned to telehealth visits will have telehealth visits alternating with clinic visits every two weeks until the end of pregnancy week 31. Those assigned to telehealth visits will also have five sessions with a health coach via telephone or video from the time of enrollment until the end of pregnancy week 36.
Key Dates
- Start date
- Apr 22, 2026
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Telehealth CycleParticipants in this arm will be provided telehealth visits in addition to the blood pressure telemonitoring.
- Active Comparator: Standard of CareIn person clinic visits
Primary Outcome Measure
Feasibility of telehealth with remote BP telemonitoring compared to standard care [ Time Frame: Gestational Week 31 ]
Central Contacts
- Ejiro Obioma, MBBS MMCi704-355-2000
- Aderonke Adeniyi, MD, MS337 713 2278
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 |
Find similar trials in Winston-Salem, NC
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE USRecruiting · Duke University · Charlotte, North Carolina